Glaxosmithkline Pharmaceuticals informs about issue of duplicate share certificates

27 Feb 2024 Evaluate
Pursuant to Regulation 39 and other application regulations of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the ‘Regulations’), Glaxosmithkline Pharmaceuticals has informed that Registrar and Transfer Agent of Company KFin Technologies has received request for issue of duplicate Share Certificates from Shareholder. Details enclosed.

The above information is a part of company’s filings submitted to BSE.

Glaxosmithkline Phar Share Price

2392.95 23.10 (0.97%)
14-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1700.55
Dr. Reddys Lab 1186.45
Cipla 1434.60
Zydus Lifesciences 884.00
Lupin 2195.00
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×